Biglari Capital Corp. disclosed 8 US equity positions worth $1.1bn in its Q3 2016 13F filing. Its largest position is CBRL at 56.3% of the reported book, followed by BIGLARI HLDGS INC and VALEANT PHARMACEUTICALS INTL. Versus Q2 2016 it opened 0 new positions, added to 0, reduced 1 and exited 2.
$1.1bn
Reported equity book
Sum of the long US equity positions in the filing, at the values filed. Options are excluded.
8
Positions
Distinct securities in the equity book with a reported value above zero. Options are excluded.
56.3%
Largest position
The largest single position as a share of the reported equity book.
100%
Top 10 weight
The ten largest positions together, as a share of the reported equity book.
2
Effective positions
1 / HHI of portfolio weights: the number of equal-weight positions the book behaves like.
52
Quarters on file since Q3 2013
Quarters for which this manager's 13F holdings are on record.